<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To study the expression and significance of WT1 gene in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (AL), RT-PCR was applied to monitor WT1 gene expression in 22 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and in 69 patients with AL </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed that the positive rate of WT1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-RA and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:mp ids='MP_0011356'>RAS</z:mp> was lower than that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t (10% versus 91.7%, P &lt; 0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>WT1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> could be expressed in <z:hpo ids='HP_0000001'>all</z:hpo> subtype of AL, It was detected in 69% of newly diagnosed and relapsed patients, and in 12.5% patients CR </plain></SENT>
<SENT sid="3" pm="."><plain>There was no difference at the relative expression level between newly diagnosed AL patients and relapsed patients, while the relative level of WT1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t was lower than that in newly diagnosed AL </plain></SENT>
<SENT sid="4" pm="."><plain>The CR rate in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients with positive expression was lower than that in patients with negative expression (41% versus 78%, P &lt;/= 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients with relative level of WT1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> &gt;/= 1 had lower CR rate (18%) than those with relative level &lt; 1 (55%) </plain></SENT>
<SENT sid="6" pm="."><plain>It is concluded that the expression of WT1 gene in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t was higher than that in patients with RA and <z:mp ids='MP_0011356'>RAS</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>The detection of WT1 gene may be useful for assessing disease progress of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The expression of WT1 gene and its expression level have associated with the prognosis of newly diagnosed patients with AL, that WT1 gene may be an independent prognostic factor in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>